S. Sala

Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND).

A. Santoro, S. Bozzarelli, L. Rimassa, 2019, Future oncology.

Activity of regorafenib in advanced pretreated soft tissue sarcoma

A. Santoro, S. Bozzarelli, L. Giordano, 2020, Medicine.

Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey

E. Vasile, V. Torri, L. Cavanna, 2023, ESMO open.